AutoIVF, Inc.
About AutoIVF, Inc.
AutoIVF Inc. is a Natick, Massachusetts-based biotechnology company founded in 2019 that specializes in automating in vitro fertilization processes. Its flagship OvaReady system uses chip-based microfluidic technology to automate egg retrieval, preparation, and related embryology steps, reducing operator variability and enabling more consistent outcomes. The company aims to integrate into existing IVF labs to improve reproducibility, expand access to high-quality fertility care, and support global democratization of IVF. It has also published research in Nature Medicine on oocyte functionality in IVF cases.
- 🔗 Dealroom.co | AutoIVF Raises $16M in Funding Round
- 🔗 AutoIVF Funding Round round (May 2025)
- 🔗 AutoIVF - 2025 Funding Rounds & List of Investors - Tracxn
- 🔗 AutoIVF - 2026 Company Profile, Team, Funding & Competitors - Tracxn
- 🔗 AutoIVF - Products, Competitors, Financials, Employees, Headquarters Locations
Investors
Key highlights
- AutoIVF's OvaReady system automates egg collection and preparation to eliminate operator variability.
- Led by CEO Ravi Kapur, the company has raised funding including grants and a round backed by Vitrolife.
- Vitrolife's Erin Schardt joined the AutoIVF board following the investment.
- Research published in Nature Medicine highlights that over 50% of IVF cases may miss functional oocytes.
- The company is based at 22 Strathmore Road, Suite 317, Natick, MA.
Ask StreetZero about AutoIVF, Inc.
Put our AI to work on this deal.
Similar companies
Other Biotechnology deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account